Search our Database of Scientific Publications and Authors

I’m looking for a

    821 results match your criteria Assay and drug development technologies[Journal]

    1 OF 17

    Improving Comprehension Efficiency of High Content Screening Data Through Interactive Visualizations.
    Assay Drug Dev Technol 2017 Aug/Sep;15(6):247-256
    2 Department of Information and Computing Sciences, Utrecht University , Utrecht, Netherlands .
    In this study, an experiment is conducted to measure the performance in speed and accuracy of interactive visualizations. A platform for interactive data visualizations was implemented using Django, D3, and Angular. Using this platform, a questionnaire was designed to measure a difference in performance between interactive and noninteractive data visualizations. Read More

    Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Assay Drug Dev Technol 2017 Aug/Sep;15(6):280-296
    1 Molecular Devices, LLC , Sunnyvale, California.
    Development of more complex, biologically relevant, and predictive cell-based assays for compound screening is a major challenge in drug discovery. The focus of this study was to establish high-throughput compatible three-dimensional (3D) cardiotoxicity assays using human induced pluripotent stem cell-derived cardiomyocytes. Using both high-content imaging and fast kinetic fluorescence imaging, the impact of various compounds on the beating rates and patterns of cardiac spheroids was monitored by changes in intracellular Ca(2+) levels with calcium-sensitive dyes. Read More

    How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.
    Assay Drug Dev Technol 2017 Aug/Sep;15(6):239-246. Epub 2017 Aug 11.
    1 Novartis Institutes for BioMedical Research (NIBR) , Chemical Biology and Therapeutics (CBT), Basel, Switzerland .
    Since 2011, phenotypic screening has been a trend in the pharmaceutical industry as well as in academia. This renaissance was triggered by analyses that suggested that phenotypic screening is a superior strategy to discover first-in-class drugs. Despite these promises and considerable investments, pharmaceutical research organizations have encountered considerable challenges with the approach. Read More

    Exploiting Analysis of Heterogeneity to Increase the Information Content Extracted from Fluorescence Micrographs of Transgenic Zebrafish Embryos.
    Assay Drug Dev Technol 2017 Aug/Sep;15(6):257-266. Epub 2017 Aug 11.
    1 University of Pittsburgh Drug Discovery Institute , Pittsburgh, Pennsylvania.
    Zebrafish embryos are a near-ideal animal model for drug discovery because of their high genetic and physiological similarity to mammals, small size, high fecundity, and optical transparency. The latter properties make zebrafish at larval stages especially suited for high-content analysis and high throughput screening (HTS). However, inherent biological complexity and the inability to screen multiple specimens in a single well present a challenge for HTS because limiting replicates and high variability often prevent assays from reaching the stringent performance criteria demanded of large-scale screening assays. Read More

    High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells.
    Assay Drug Dev Technol 2017 Aug/Sep;15(6):267-279. Epub 2017 Aug 3.
    1 Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas.
    Endothelial cells (ECs) play a major role in blood vessel formation and function. While there is longstanding evidence for the potential of chemical exposures to adversely affect EC function and vascular development, the hazard potential of chemicals with respect to vascular effects is not routinely evaluated in safety assessments. Induced pluripotent stem cell (iPSC)-derived ECs promise to provide a physiologically relevant, organotypic culture model that is amenable for high-throughput (HT) EC toxicant screening and may represent a viable alternative to traditional in vitro models, including human umbilical vein endothelial cells (HUVECs). Read More

    High-Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-I Synthesis.
    Assay Drug Dev Technol 2017 Jul 25. Epub 2017 Jul 25.
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Florida College of Medicine-Jacksonville , Jacksonville, Florida.
    Apolipoprotein A-I (apo A-I) is the primary antiatherogenic protein in high-density lipoprotein (HDL). Despite the controversy as to the clinical effectiveness of raising HDL, the search is ongoing for safe and effective drugs that increase HDL and apo A-I levels. To identify novel compounds that can increase hepatic apo A-I production, two drug libraries were screened. Read More

    Development of Three Orthogonal Assays Suitable for the Identification and Qualification of PIKfyve Inhibitors.
    Assay Drug Dev Technol 2017 Jul;15(5):210-219
    1 Department of Small Molecule Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc. , Ridgefield, Connecticut.
    FYVE-type zinc finger-containing phosphoinositide kinase (PIKfyve) catalyzes the formation of phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) from phosphatidylinositol 3-phosphate (PI(3)P). PIKfyve has been implicated in multiple cellular processes, and its role in the regulation of toll-like receptor (TLR) pathways and the production of proinflammatory cytokines has sparked interest in developing small-molecule PIKfyve inhibitors as potential therapeutics to treat autoimmune and inflammatory diseases. We developed three orthogonal assays to identify and qualify small-molecule inhibitors of PIKfyve: (1) a purified component microfluidic enzyme assay that measures the conversion of fluorescently labeled PI(3)P to PI(3,5)P2 by purified recombinant full-length human 6His-PIKfyve (rPIKfyve); (2) an intracellular protein stabilization assay using the kinase domain of PIKfyve expressed in HEK293 cells; and (3) a cell-based functional assay that measures the production of interleukin (IL)-12p70 in human peripheral blood mononuclear cells stimulated with TLR agonists lipopolysaccharide and R848. Read More

    Identification of Antipneumococcal Molecules Effective Against Different Streptococcus pneumoniae Serotypes Using a Resazurin-Based High-Throughput Screen.
    Assay Drug Dev Technol 2017 Jul;15(5):198-209
    1 Antibacterial Resistance Research Laboratory, Discovery Biology Department, Institut Pasteur Korea , Seongnam-si, Korea.
    Streptococcus pneumoniae is a major human pathogen, causing around 1.6 million deaths worldwide each year. By optimizing a resazurin-based assay to detect S. Read More

    Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.
    Assay Drug Dev Technol 2017 Jul;15(5):220-236
    1 Vala Sciences Inc. , San Diego, California.
    Postchemotherapy cognitive impairment (PCCI) is commonly exhibited by cancer patients treated with a variety of chemotherapeutic agents, including the endocrine disruptor tamoxifen (TAM). The etiology of PCCI is poorly understood. Our goal was to develop high-throughput assay methods to test the effects of chemicals on neuronal function applicable to PCCI. Read More

    Analytical Characterization of Methyl-β-Cyclodextrin for Pharmacological Activity to Reduce Lysosomal Cholesterol Accumulation in Niemann-Pick Disease Type C1 Cells.
    Assay Drug Dev Technol 2017 May/Jun;15(4):154-166
    1 National Center for Advancing Translational Sciences, National Institutes of Health , Bethesda, Maryland.
    Methyl-β-cyclodextrin (MβCD) reduces lysosomal cholesterol accumulation in Niemann-Pick disease type C1 (NPC1) patient fibroblasts. However, the pharmacological activity of MβCD reported by different laboratories varies. To determine the potential causes of this variation, we analyzed the mass spectrum characteristics, pharmacological activity of three preparations of MβCDs, and the protein expression profiles of NPC1 patient fibroblasts after treatment with different sources of MβCDs. Read More

    A High-Throughput Screening Assay for NKCC1 Cotransporter Using Nonradioactive Rubidium Flux Technology.
    Assay Drug Dev Technol 2017 May/Jun;15(4):167-177
    1 Aurora Biomed Inc. , Vancouver, Canada .
    A high-throughput screening (HTS) assay was developed for cotransporter, NKCC1, which is a potential target for the treatment of diverse disorders. This nonradioactive rubidium flux assay coupled with ion channel reader series provides a working screen for this target expressed in human embryonic kidney (HEK) cell line. An eightfold window of detection was achieved with the optimized assay. Read More

    High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging.
    Assay Drug Dev Technol 2017 May/Jun;15(4):178-188. Epub 2017 May 19.
    1 InvivoSciences, Inc. , Madison, Wisconsin.
    Electrophysiology of excitable cells, including muscle cells and neurons, has been measured by making direct contact with a single cell using a micropipette electrode. To increase the assay throughput, optical devices such as microscopes and microplate readers have been used to analyze electrophysiology of multiple cells. We have established a high-throughput (HTP) analysis of action potentials (APs) in highly enriched motor neurons and cardiomyocytes (CMs) that are differentiated from human induced pluripotent stem cells (iPSCs). Read More

    Investigation of Classical Organic and Ionic Liquid Cosolvents for Early-Stage Screening in Fragment-Based Inhibitor Design with Unrelated Bacterial and Human Dihydrofolate Reductases.
    Assay Drug Dev Technol 2017 May/Jun;15(4):141-153. Epub 2017 Apr 20.
    1 Département de Biochimie, Université de Montréal , Québec, Canada .
    Drug design by methods such as fragment screening requires effective solubilization of millimolar concentrations of small organic compounds while maintaining the properties of the biological target. We investigate four organic solvents and three 1-butyl-3-methylimidazolium (BMIm)-based ionic liquids (ILs) as cosolvents to establish conditions for screening two structurally unrelated dihydrofolate reductases (DHFRs) that are prime drug targets. Moderate concentrations (10%-15%) of cosolvents had little effect on inhibition of the microbial type II R67 DHFR and of human DHFR (hDHFR), while higher concentrations of organic cosolvents generally decreased activity of both DHFRs. Read More

    Validating the Predicted Effect of Astemizole and Ketoconazole Using a Drosophila Model of Parkinson's Disease.
    Assay Drug Dev Technol 2017 Apr;15(3):106-112
    Parkure Ltd. , Edinburgh, United Kingdom .
    Parkinson's disease is a growing threat to an ever-ageing population. Despite progress in our understanding of the molecular and cellular mechanisms underlying the disease, all therapeutics currently available only act to improve symptoms and do not stop the disease process. It is therefore imperative that more effective drug discovery methods and approaches are developed, validated, and used for the discovery of disease-modifying treatments for Parkinson's. Read More

    Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
    Assay Drug Dev Technol 2017 Apr 5;15(3):113-119. Epub 2017 Apr 5.
    4 Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee.
    The potential impact of using human genetic data linked to longitudinal electronic medical records on drug development is extraordinary; however, the practical application of these data necessitates some organizational innovations. Vanderbilt has created resources such as an easily queried database of >2.6 million de-identified electronic health records linked to BioVU, which is a DNA biobank with more than 230,000 unique samples. Read More

    Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain the Antibacterial Activity of Nonantibiotic Food and Drug Administration Drugs.
    Assay Drug Dev Technol 2017 Apr 27;15(3):89-105. Epub 2017 Mar 27.
    1 Arab International University Faculty of Pharmacy , Daraa, Syrian Arab Republic.
    Discovering of new and effective antibiotics is a major issue facing scientists today. Luckily, the development of computer science offers new methods to overcome this issue. In this study, a set of computer software was used to predict the antibacterial activity of nonantibiotic Food and Drug Administration (FDA)-approved drugs, and to explain their action by possible binding to well-known bacterial protein targets, along with testing their antibacterial activity against Gram-positive and Gram-negative bacteria. Read More

    DissolvIt: An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs.
    Assay Drug Dev Technol 2017 Feb/Mar;15(2):77-88
    5 Astra Zeneca Ltd , Lund, Sweden .
    The main purpose of this work was to develop an in vitro method for simulating the dissolution and absorption of inhaled dry powder drugs that also mimics systemic pharmacokinetic data. A second purpose was to evaluate this method. DissolvIt(®) was developed as a simulation of the air-blood barrier of the upper airways, constituting: "airborne" particles deposited on a glass cover slip, a mucus simulant, a polycarbonate (basal) membrane, and a pumped albumin buffer simulating the pulmonary blood flow. Read More

    Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors.
    Assay Drug Dev Technol 2017 Feb/Mar;15(2):53-63
    1 Department of Pediatrics Infectious Diseases, Emory University School of Medicine , Atlanta, Georgia .
    HIV-1 entry and fusion with target cells is an important target for antiviral therapy. However, a few currently approved treatments are not effective as monotherapy due to the emergence of drug resistance. This consideration has fueled efforts to develop new bioavailable inhibitors targeting different steps of the HIV-1 entry process. Read More

    A Three-Dimensional Lymphatic Endothelial Cell Tube Formation Assay to Identify Novel Kinases Involved in Lymphatic Vessel Remodeling.
    Assay Drug Dev Technol 2017 Jan;15(1):30-43
    1 Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre , Melbourne, Victoria, Australia .
    The lymphatic system is a series of vessels that transport cells and excess fluid from tissues to the blood vascular system. Normally quiescent, the lymphatics can grow or remodel in response to developmental, immunological, or cells pathological stimuli. Lymphatic vessels comprise lymphatic endothelial cells (LECs) that can respond to external growth factors by undergoing proliferation, migration, adhesion, and tube and lumen formation into new vessel structures, a process known as lymphangiogenesis. Read More

    Toward High-Throughput and Multiplexed Imaging of Genome Organization.
    Assay Drug Dev Technol 2017 Jan;15(1):11-14
    Department of Genetics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
    Dr. Eric Joyce from the Department of Genetics at the University of Pennsylvania was awarded The President's Innovation award at the annual Society of Biomolecular Imaging and Informatics meeting held in Boston, September 2016. Chromosome interactions are a fundamental aspect of nuclear organization that can activate and silence genes or even direct chromosome rearrangements. Read More

    Multiplexed Single-Cell Imaging: Past, Present, and Future.
    Assay Drug Dev Technol 2017 Jan 22;15(1):8-10. Epub 2016 Dec 22.
    Laboratory of Systems Pharmacology, HMS LINCS Center , Harvard Medical School Boston, Boston, Massachusetts.
    Jia-Ren Lin from the Laboratory of Systems Pharmacology at Harvard Medical School was awarded best poster at the annual Society of Biomolecular Imaging and Informatics meeting held in Boston, September 2016. His work focuses on single-cell imaging, especially on developing new methods for simultaneously detecting many antigens, named cyclic immunofluorescence (CycIF). This method could be applied in different stages of drug development, from discovery phase, preclinical research to clinical research. Read More

    Determination of Interference During In Vitro Pyrogen Detection: Development and Characterization of a Cell-Based Assay.
    Assay Drug Dev Technol 2017 Feb/Mar;15(2):64-76. Epub 2016 Dec 20.
    1 Department of Biomolecular Sciences, Section of Biochemistry and Molecular Biology, University of Urbino "Carlo Bo ," Urbino, Italy .
    Contamination of pharmaceutical products and medical devices with pyrogens such as endotoxins is the most common cause of systemic inflammation and, in worst cases, of septic shock. Thus, quantification of pyrogens is crucial. The limulus amebocyte lysate (LAL)-based assays are the reference tests for in vitro endotoxin detection, in association with the in vivo rabbit pyrogen test (RPT), according to European Pharmacopoeia (EP 2. Read More

    Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
    Assay Drug Dev Technol 2016 Dec;14(10):567-572
    2 DST-FIST and UGC-SAP Sponsored School of Life Sciences, SRTM University , Nanded, India .
    Tramadol is a synthetic, centrally acting low-affinity agonist of μ-opioid receptors in humans. It is used as an analgesic and is shown to have local anesthetic action. In this study, we have tried to explore its anti-Candida potential. Read More

    Revisiting Repurposing.
    Assay Drug Dev Technol 2016 Dec;14(10):554-556
    Department of Pharmacology, University of Virginia , Charlottesville, Virginia.
    Drug repurposing can be a cost-effective strategy to identify new small molecule-based therapies. Thus, drug repurposing significantly influences the discovery of therapeutics, particularly for rare and neglected diseases, which are often constrained by limited research and development funds. The push for translational science and access to drug discovery-associated resources such as high throughput screening instrumentation, assay development expertise, and Food and Drug Administration-approved drug libraries have intensified interest in drug repurposing. Read More

    An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria.
    Assay Drug Dev Technol 2016 Nov;14(9):524-534
    1 Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa , UNL, Lisbon, Portugal .
    Infections caused by Mycobacterium tuberculosis and other mycobacteria are major challenges for global public health. Particularly worrisome are infections caused by multidrug-resistant bacteria, which are increasingly difficult to treat because of the loss of efficacy of the current antibacterial agents, a problem that continues to escalate worldwide. There has been a limited interest and investment on the development of new antibacterial agents in the past decades. Read More

    Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay.
    Assay Drug Dev Technol 2016 Nov 2;14(9):543-550. Epub 2016 Nov 2.
    1 Department of Medicine I, Division: Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna , Vienna, Austria .
    Levels of soluble Axl (sAxl) are routinely assessed in human sera by sandwich enzyme-linked immunosorbent assay (ELISA). Although sAxl values are suggested to diagnose different types of disorders, no uniform ELISA method is available, allowing the reliable interassay comparison between results. Furthermore, little is known about the stability of sAxl under storage conditions, which is a relevant parameter for biomedical trials. Read More

    Analytical Application of Flow Immunosensor in Detection of Thyroxine and Triiodothyronine in Serum.
    Assay Drug Dev Technol 2016 Nov 1;14(9):535-542. Epub 2016 Nov 1.
    1 Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University , Riyadh, Saudi Arabia .
    In this study, an immunosensor based on kinetic exclusion analysis (KinExA) was used for thyroxine (T4) and triiodothyronine (T3) estimation. A KinExA™ 3200 instrument was used for this analysis, which is an automated flow fluorimeter designed to separate free unbound antibody binding sites in reaction mixtures of antibody, antigen, and antibody-antigen complex. A T3-BSA- and T4-BSA-coated polymethyl methacrylate (PMMA) bead microcolumn is generated inside the flow cell of the instrument. Read More

    Effect-Size Measures as Descriptors of Assay Quality in High-Content Screening: A Brief Review of Some Available Methodologies.
    Assay Drug Dev Technol 2017 Jan 27;15(1):15-29. Epub 2016 Oct 27.
    Bindley Bioscience Center, Purdue University , West Lafayette, Indiana.
    The field of high-content screening (HCS) typically uses measures of screen quality conceived for fairly straightforward high-throughput screening (HTS) scenarios. However, in contrast to HTS, image-based HCS systems rely on multidimensional readouts reporting biological responses associated with complex cellular phenotypes. Not only is the dimensionality in which the screens operate higher, but also the scale of the individual features describing the quantified phenotypic changes is often smaller than what is seen in one-dimensional HTS platforms. Read More

    Discovery of Small Molecules That Induce Lysosomal Cell Death in Cancer Cell Lines Using an Image-Based Screening Platform.
    Assay Drug Dev Technol 2016 Oct 22;14(8):489-510. Epub 2016 Sep 22.
    1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands .
    The lysosomal cell death (LCD) pathway is a caspase 3-independent cell death pathway that has been suggested as a possible target for cancer therapy, making the development of sensitive and specific high-throughput (HT) assays to identify LCD inducers highly desirable. In this study, we report a two-step HT screening platform to reliably identify such molecules. First, using a robust HT primary screen based on propidium iodide uptake, we identified compounds that kill through nonapoptotic pathways. Read More

    A Phenotypic High-Content Screening Assay to Identify Regulators of Membrane Protein Localization.
    Assay Drug Dev Technol 2016 Oct 23;14(8):478-488. Epub 2016 Sep 23.
    1 Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre , Victoria, Australia .
    Correct subcellular localization of proteins is a requirement for appropriate function. This is especially true in epithelial cells, which rely on the precise localization of a diverse array of epithelial polarity and cellular adhesion proteins. Loss of cell polarity and adhesion is a hallmark of cancer, and mislocalization of core polarity proteins, such as Scribble, is observed in a range of human epithelial tumors and is prognostic of poor survival. Read More

    HC StratoMineR: A Web-Based Tool for the Rapid Analysis of High-Content Datasets.
    Assay Drug Dev Technol 2016 Oct 16;14(8):439-452. Epub 2016 Sep 16.
    1 Department of Cell Biology, Centre for Molecular Medicine , UMC Utrecht, Utrecht, Netherlands .
    High-content screening (HCS) can generate large multidimensional datasets and when aligned with the appropriate data mining tools, it can yield valuable insights into the mechanism of action of bioactive molecules. However, easy-to-use data mining tools are not widely available, with the result that these datasets are frequently underutilized. Here, we present HC StratoMineR, a web-based tool for high-content data analysis. Read More

    Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.
    Assay Drug Dev Technol 2016 Dec 15;14(10):557-566. Epub 2016 Sep 15.
    1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus , Aurora, Colorado.
    Drug adverse events (AEs) are a major health threat to patients seeking medical treatment and a significant barrier in drug discovery and development. AEs are now required to be submitted during clinical trials and can be extracted from ClinicalTrials.gov ( https://clinicaltrials. Read More

    1 OF 17